The downstream functional effects of R-2HG administration in IDH1 or 2 wild type cells were all anti-tumour ones, and the results of the experiments had also important implications regarding the possibility of combining R-2HG with standard chemotherapy in IDH1/2 wild type tumours. The gene discussed is IDH1; the disease is neoplasm.